Adar1 Capital Management, LLC 89bio, Inc. Transaction History

Adar1 Capital Management, LLC

  • $530 Billion
  • Q2 2024

A detailed history of Adar1 Capital Management, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 5,560 shares of ETNB stock, worth $44,424. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,560
Previous 3,060 81.7%
Holding current value
$44,424
Previous $35.6 Million 25.04%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$7.31 - $10.9 $18,275 - $27,250
2,500 Added 81.7%
5,560 $44.5 Million
Q1 2024

May 15, 2024
BUY
$8.13 - $13.77 $21,381 - $36,215
2,630 Added 611.63%
3,060 $35.6 Million
Q4 2023

Feb 14, 2024
BUY
$6.66 - $16.03 $2,863 - $6,892
430 New
430 $4.8 Million

About 89bio, Inc.

ETNB Quotes by TradingView
  • Ticker ETNB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,484,500
  • Market Cap $371M
  • Description
  • 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...
More about ETNB
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email